Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.
Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, Farrerons J, Karasik A, Mellstrom D, Ng KW, Stepan JJ, Powles TJ, Morrow M, Costa A, Silfen SL, Walls EL, Schmitt H, Muchmore DB, Jordan VC, Ste-Marie LG. Cauley JA, et al. Among authors: eckert s. Breast Cancer Res Treat. 2001 Jan;65(2):125-34. doi: 10.1023/a:1006478317173. Breast Cancer Res Treat. 2001. PMID: 11261828 Clinical Trial.
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. Cummings SR, et al. Among authors: eckert s. JAMA. 1999 Jun 16;281(23):2189-97. doi: 10.1001/jama.281.23.2189. JAMA. 1999. PMID: 10376571 Clinical Trial.
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Ettinger B, et al. Among authors: eckert s. JAMA. 1999 Aug 18;282(7):637-45. doi: 10.1001/jama.282.7.637. JAMA. 1999. PMID: 10517716 Clinical Trial.
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
Kantarjian HM, Erba HP, Claxton D, Arellano M, Lyons RM, Kovascovics T, Gabrilove J, Craig M, Douer D, Maris M, Petersdorf S, Shami PJ, Yeager AM, Eckert S, Abichandani R, Faderl S. Kantarjian HM, et al. Among authors: eckert s. J Clin Oncol. 2010 Feb 1;28(4):549-55. doi: 10.1200/JCO.2009.23.3130. Epub 2009 Dec 21. J Clin Oncol. 2010. PMID: 20026805 Clinical Trial.
The Heisenberg-RIXS instrument at the European XFEL.
Schlappa J, Ghiringhelli G, Van Kuiken BE, Teichmann M, Miedema PS, Delitz JT, Gerasimova N, Molodtsov S, Adriano L, Baranasic B, Broers C, Carley R, Gessler P, Ghodrati N, Hickin D, Hoang LP, Izquierdo M, Mercadier L, Mercurio G, Parchenko S, Stupar M, Yin Z, Martinelli L, Merzoni G, Peng YY, Reuss T, Sreekantan Nair Lalithambika S, Techert S, Laarmann T, Huotari S, Schroeter C, Langer B, Giessel T, Buchheim J, Gwalt G, Sokolov A, Siewert F, Buechner R, Vaz da Cruz V, Eckert S, Liu CY, Sohrt C, Weniger C, Pietzsch A, Neppl S, Senf F, Scherz A, Föhlisch A. Schlappa J, et al. Among authors: eckert s. J Synchrotron Radiat. 2025 Jan 1. doi: 10.1107/S1600577524010890. Online ahead of print. J Synchrotron Radiat. 2025. PMID: 39705248
474 results